Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma. - Wikidata - awgldk - TriplyDB

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

http://www.wikidata.org/entity/Q35656610

about

PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.Podocalyxin as a Prognostic Marker in Gastric Cancer Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis.Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma.Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability.Measurement of serum PODXL concentration for detection of pancreatic cancer.Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancer

P2860

Q33600992-7C47F8A8-CFB9-4DD6-A992-03D7B1DC0658 Q35870705-1E4CE353-195F-4FEA-8889-476A79509439 Q36091414-2A0F0B3B-77B3-4E3D-9679-0800FA0CB4A1 Q36236781-94E547A8-1D80-4E39-B6E0-DD64112443E4 Q37375238-96E0CBEA-9239-4148-BA68-70DBC1803811 Q37735632-C6172CA5-4F09-4942-8136-D7E31AACBED8 Q47336139-59BDA696-27AF-4DB1-90B1-52AD7D7A879E Q47860795-C3363A5F-22DC-4B46-BD0A-C51C62CF3AE8 Q52626660-8BCAE865-D816-43EF-8F0A-44EF09D0410A Q57112164-EB92CDED-D73F-4F52-B591-F6EF6BEAA482

P2860

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

http://www.wikidata.org/entity/Q35656610

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

@ast

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

@en

type

label

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

@ast

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

@en

prefLabel

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

@ast

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

@en

P1433

Q35656610-02A14FC0-65E6-4D8C-B8F4-75280E58FEEF

P1476

Q35656610-7BECFCB0-1056-4964-A49D-344BF69FA9B1

P2093

Q35656610-6E9BE4B8-4CB0-40BB-B2D9-5C617E33E062

Q35656610-82756DEB-E8D8-41D3-987A-A157CB6C1148

Q35656610-9A1C8BD1-C60D-4F18-930F-589E4967DA7E

Q35656610-9EE612A1-BF0D-4C53-9047-9E72BE51D77C

Q35656610-A6A3DCB1-010D-45EE-8C4D-E2A18AE18D8F

Q35656610-BF89CE6B-E40E-441D-ACDB-B7CA066F5203

Q35656610-E8BC01C7-7357-493C-88B3-C38563032105

P2860

Q35656610-0C588A1D-8FB9-41A3-AF1C-586E43631305

Q35656610-21CDAEE3-B059-4019-A45E-00458EDB4AD7

Q35656610-2B392D44-4A51-4EF2-A6F9-D2EB030C09E6

Q35656610-2F15DCF6-DCAD-4BA4-8D70-292ED86BA58D

Q35656610-668F4BBC-03ED-4CAD-BF87-23F1EA79151C

Q35656610-71651ECC-550E-43FB-BB17-9D8E845F925F

Q35656610-75CF2808-ECD4-49A9-A057-B4C02C90703F

Q35656610-81F7EFFE-AC11-4AFB-89BC-9404B4AFBB86

Q35656610-88027A3A-2715-4B49-A2B3-9924FBDEDE6D

Q35656610-89C92AA1-1DC8-446B-8D81-F8C68C2116F2

P304

Q35656610-DEAAABB9-3EC2-4AC8-B6C7-77A5783AE8AD

P31

Q35656610-1C909BEB-ABEA-4156-9BC1-85906A7670D5

P356

Q35656610-D4BEA704-F01B-436B-9149-F445C394747D

P407

Q35656610-11B7C172-22A6-443E-93A7-D24212818E20

P433

Q35656610-97ED3001-0BDF-4480-BE9C-C31A50C322CD

P478

Q35656610-2F22D5C3-4CD3-4649-A922-99C4A17C66B0

P50

Q35656610-2CCE2459-1070-4844-B712-EFA4B69427B0

Q35656610-CBF69EFB-B583-4BBA-A955-B0560F399F4D

P577

Q35656610-6D850041-9C3D-43B7-B717-D9B0DCB09F9F

P5875

Q35656610-26B3C416-7A3F-4709-8A17-5341F85B617F

P698

Q35656610-0EC39BB0-8EC1-478E-A7D5-9F8958A7E297

P921

Q35656610-0B3D2354-B2CB-4652-9C51-93F635589B7F

P932

Q35656610-FAE2DA5C-EBA4-4AA6-8924-83A5A1534A48

P356

JOURNAL.PONE.0129012

P1433

P1476

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

@en

P2093

Anne Juuti

http://www.w3.org/2001/XMLSchema#string

Caj Haglund

http://www.w3.org/2001/XMLSchema#string

Christian Fermér

http://www.w3.org/2001/XMLSchema#string

Hanna Seppänen

http://www.w3.org/2001/XMLSchema#string

Kapo Saukkonen

http://www.w3.org/2001/XMLSchema#string

Olle Nilsson

http://www.w3.org/2001/XMLSchema#string

Stig Nordling

http://www.w3.org/2001/XMLSchema#string

P2860

The CD34-related molecule podocalyxin is a potent inducer of microvillus formation

Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer

Cancer statistics, 2014

Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells

Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells

Pancreatic cancer

A comparative study of two PODXL antibodies in 840 colorectal cancer patients.

P304

e0129012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0129012

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Jaana Hagström

P577

2015-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279210335

http://www.w3.org/2001/XMLSchema#string

P698

26053486

http://www.w3.org/2001/XMLSchema#string

P921

P932

4459962

http://www.w3.org/2001/XMLSchema#string